Contact Molecules for Homologous Proteins | ||||
![]() [Summary Bars] |
![]() [SiteTable] |
|
![]() [Back to Search Page] |
![]() [Back to HOMCOS] |
![]() [SupCon3D] |
![]() [help] |
seq_id(%): [0] [30] [40] [50] [60] [70] [80] [90] [95] [100] | ![]() [show] [download] [help] |
PID | QueryLength | Homolgous Sequence in PDB | UniProt Query | TITLE |
2931865 | 365 | 94 | P04439(HLAA_HUMAN) | RecName: Full=HLA class I histocompatibility antigen, A alpha chain;AltName: Full=Human leukocyte antigen A; Short=HLA-A;Flags: Precursor; |
QUERYSEQ |
MAVMAPRTLLLLLSGALALTQTWAGSHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYWDQETRNVKAQSQTDRVDLGTLRGYYNQSEAGSHTIQIMYGCDVGSDGRFLRGYRQDAYDGKDYIAL NEDLRSWTAADMAAQITKRKWEAAHEAEQLRAYLDGTCVEWLRRYLENGKETLQRTDPPKTHMTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRWEL SSQPTIPIVGIIAGLVLLGAVITGAVVAAVMWRRKSSDRKGGSYTQAASSDSAQGSDVSLTACKV |
365 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
region | name | description |
![]() ![]() |
1-24 | SIGNAL | |
![]() ![]() |
25-365 | CHAIN | /note="HLA class I histocompatibility antigen, A alpha chain" /id="PRO_0000018815" |
![]() ![]() ![]() |
25-308 | TOPO_DOM | /note="Extracellular" |
![]() ![]() ![]() |
309-332 | TRANSMEM | /note="Helical" |
![]() ![]() |
333-365 | TOPO_DOM | /note="Cytoplasmic" |
![]() ![]() ![]() |
209-295 | DOMAIN | /note="Ig-like C1-type" |
![]() ![]() ![]() |
3-11 | REGION | /note="VL9 epitope" |
![]() ![]() ![]() |
25-114 | REGION | /note="Alpha-1" |
![]() ![]() ![]() |
115-206 | REGION | /note="Alpha-2" |
![]() ![]() ![]() |
207-298 | REGION | /note="Alpha-3" |
![]() ![]() ![]() |
299-308 | REGION | /note="Connecting peptide" |
![]() ![]() |
339-365 | REGION | /note="Disordered" |
![]() ![]() ![]() |
341-359 | COMPBIAS | /note="Polar residues" |
![]() ![]() ![]() |
31-31 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" |
![]() ![]() ![]() |
97-97 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" |
![]() ![]() ![]() |
108-108 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" |
![]() ![]() ![]() |
140-140 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="2" /ligand_note="self-peptide antigen" |
![]() ![]() ![]() |
167-167 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" |
![]() ![]() ![]() |
170-170 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" |
![]() ![]() ![]() |
183-183 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" |
![]() ![]() ![]() |
183-183 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="2" /ligand_note="self-peptide antigen" |
![]() ![]() ![]() |
195-195 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
1-365 | DISORDER | predicted by DISOPRED |
![]() |
|||||||
365 | |||||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
pdb_id | a1 | identity[%]2 | description | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 99.6 | 1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 99.6 | 1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 100.0 | 1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 100.0 | HLAA_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 100.0 | HLAA_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 100.0 | HLAA_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 100.0 | HLAA_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 100.0 | 1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 100.0 | 1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 100.0 | HLAA_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 100.0 | 1A03_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-3 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 100.0 | HLAA_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 100.0 | HLAA_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 100.0 | 1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 100.0 | 1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 100.0 | HLAA_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.5 | U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.5 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 97.5 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.5 | U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | 97.5 | A0A583ZB34_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 97.5 | U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.5 | 1A11_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-11 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.5 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 97.5 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 97.5 | F6IQY1_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | 97.5 | MHC class I antigen (Fragment) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 97.5 | Q5S3G3_HUMAN HLA class I histocompatibility antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 97.5 | Q5S3G3_HUMAN HLA class I histocompatibility antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 97.5 | 1A11_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-11 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.5 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.5 | U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.5 | Q5S3G3_HUMAN HLA class I histocompatibility antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.5 | Q5S3G3_HUMAN HLA class I histocompatibility antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.5 | A0A583ZB34_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 97.5 | A0A583ZB34_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.5 | A0A583ZB34_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R | 97.4 | A0A6M6CC39_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O | 97.4 | A0A6M6CC39_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | 97.4 | A0A6M6CC39_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | 97.4 | A0A6M6CC39_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 97.4 | U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | A0A6M6CC39_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | F6IQY1_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 97.4 | MHC class I antigen (Fragment) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 97.4 | Q5S3G3_HUMAN HLA class I histocompatibility antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | 97.4 | A0A583ZB34_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | 97.4 | A0A583ZB34_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 97.4 | A0A583ZB34_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | A0A583ZB34_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | A0A583ZB34_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | A0A583ZB34_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | 97.4 | A0A583ZB34_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 97.4 | A0A583ZB34_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 96.7 | U5YJJ6_HUMAN MHC class I antigen (Fragment) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 96.7 | U5YJJ6_HUMAN MHC class I antigen (Fragment) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
TA | 96.7 | U5YJJ6_HUMAN MHC class I antigen (Fragment) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
OA | 96.7 | U5YJJ6_HUMAN MHC class I antigen (Fragment) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
JA | 96.7 | U5YJJ6_HUMAN MHC class I antigen (Fragment) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
EA | 96.7 | U5YJJ6_HUMAN MHC class I antigen (Fragment) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Z | 96.7 | U5YJJ6_HUMAN MHC class I antigen (Fragment) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
U | 96.7 | U5YJJ6_HUMAN MHC class I antigen (Fragment) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P | 96.7 | U5YJJ6_HUMAN MHC class I antigen (Fragment) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | 96.7 | U5YJJ6_HUMAN MHC class I antigen (Fragment) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 96.7 | U5YJJ6_HUMAN MHC class I antigen (Fragment) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 96.7 | U5YJJ6_HUMAN MHC class I antigen (Fragment) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 97.4 | Q5S3G3_HUMAN HLA class I histocompatibility antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | Q5S3G3_HUMAN HLA class I histocompatibility antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 96.0 | HLA-A*02:01 | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 96.7 | HLA-A*3001 | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 96.0 | HLA-A*3003 | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 96.0 | HLA-A*3003 | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 96.0 | HLA-A*3003 | |||
1.a1:asym_id for the homologue. 2.identity[%]2:sequence identity between the query and the homologue. |
![]() |
|||||||
365 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NEF_HV1Z6 Negative factor[10 aa] | A | 89.3 /97.5 |
28 /28 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | NEF_HV1Z6 Negative factor[10 aa] | D | 86.2 /97.5 |
29 /29 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q9YYU8_9HIV1 Nef73 peptide from Protein Nef[10 aa] | A | 100.0 /100.0 |
24 /24 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MYPR_HUMAN MYELIN PROTEOLIPID PROTEIN[9 aa] | A | 100.0 /100.0 |
26 /26 |
1A03_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-3 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | D30 TCR beta chain[244 aa] | A | 100.0 /97.4 |
10 /10 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | D30 TCR beta chain[244 aa] | F | 100.0 /97.4 |
10 /10 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | D30 TCR beta chain[244 aa] | A | 100.0 /97.4 |
8 /8 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | D30 TCR beta chain[244 aa] | F | 100.0 /97.4 |
10 /10 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | T cell receptor, beta chain[237 aa] | A | 100.0 /100.0 |
6 /6 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | TPSN_HUMAN Tapasin[364 aa] | D | 100.0 /100.0 |
11 /11 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
E | CALR_HUMAN Calreticulin[365 aa] | D | 100.0 /100.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
E | CALR_HUMAN Calreticulin[364 aa] | D | 100.0 /100.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PK3CA_HUMAN wild-type PIK3CA peptide[9 aa] | A | 100.0 /100.0 |
24 /24 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PK3CA_HUMAN mutant PIK3CA peptide[9 aa] | A | 100.0 /100.0 |
28 /28 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PK3CA_HUMAN Mutant PIK3CA peptide[9 aa] | A | 100.0 /100.0 |
29 /29 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | PK3CA_HUMAN Mutant PIK3CA peptide[9 aa] | A | 100.0 /100.0 |
29 /29 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | T cell receptor, alpha chain[187 aa] | A | 100.0 /100.0 |
6 /6 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | T cell receptor, beta chain[247 aa] | A | 100.0 /100.0 |
12 /12 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NCAP_INBAC Nucleoprotein peptide[9 aa] | A | 100.0 /100.0 |
25 /25 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RASN_HUMAN KRAS peptide (VVVGAGGVGK)[10 aa] | A | 87.0 /97.4 |
23 /23 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | RASN_HUMAN KRAS peptide (VVVGAGGVGK)[10 aa] | J | 85.7 /97.5 |
28 /28 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RASN_HUMAN KRAS peptide (VVVGAGGVGK)[10 aa] | A | 88.9 /97.4 |
27 /27 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | VAL-VAL-VAL-GLY-ALA-GLY-GLY-VAL-GLY-LYS[10 aa] | A | 100.0 /100.0 |
23 /23 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | TPSN_HUMAN Tapasin[348 aa] | D | 100.0 /100.0 |
26 /26 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
C | PDIA3_HUMAN Protein disulfide-isomerase A3[459 aa] | D | 100.0 /100.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | T cell receptor, alpha chain[185 aa] | A | 100.0 /100.0 |
10 /10 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | IgG, Fab Heavy Chain V2[216 aa] | D | 100.0 /100.0 |
16 /16 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | KRAS G12V (7-16)[10 aa] | D | 100.0 /100.0 |
19 /19 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | IgG, Fab Light Chain V2[214 aa] | D | 100.0 /100.0 |
8 /8 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NCAP_I46A1 Nucleoprotein peptide[9 aa] | A | 100.0 /100.0 |
30 /30 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | NCAP_I46A1 Nucleoprotein peptide[9 aa] | D | 100.0 /100.0 |
31 /31 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CTNB1_HUMAN Catenin beta-1[9 aa] | A | 100.0 /99.6 |
23 /23 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CTNB1_HUMAN Catenin beta-1[9 aa] | A | 100.0 /99.6 |
22 /22 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike protein S1 peptide[9 aa] | A | 88.0 /97.5 |
25 /25 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | AZOBENZENE-CONTAINING PEPTIDE[7 aa] | A | 76.9 /97.5 |
13 /13 |
1A11_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-11 ALPHA.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | AZOBENZENE-CONTAINING PEPTIDE[7 aa] | C | 76.9 /97.5 |
13 /13 |
1A11_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-11 ALPHA.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | Heavy chain[216 aa] | A | 100.0 /97.4 |
10 /10 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Heavy chain[216 aa] | E | 100.0 /97.5 |
9 /9 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | Light chain[216 aa] | A | 75.0 /97.4 |
4 /4 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Light chain[215 aa] | E | 75.0 /97.5 |
4 /4 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TCR alpha[181 aa] | A | 91.7 /97.5 |
12 /12 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | M1_INBAC Matrix protein 1 peptide SALEWIKNK[9 aa] | A | 84.6 /97.5 |
26 /26 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | M1_INBAC Matrix protein 1 peptide SALEWIKNK[9 aa] | D | 86.7 /97.5 |
30 /30 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike protein S2' [10 aa] | A | 87.5 /97.5 |
32 /32 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | SPIKE_SARS2 Spike protein S2' [10 aa] | A | 86.7 /97.5 |
30 /30 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | SPIKE_SARS2 Spike protein S2' [10 aa] | C | 84.6 /97.5 |
26 /26 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | SPIKE_SARS2 Spike protein S2' [10 aa] | E | 85.7 /97.5 |
28 /28 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 97.1 /97.5 |
35 /35 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 97.0 /97.5 |
33 /33 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 97.1 /97.5 |
35 /35 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 97.2 /97.5 |
36 /36 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 96.7 /97.5 |
30 /30 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 96.8 /97.4 |
31 /31 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA-2-MICROGLOBULIN[98 aa] | A | 100.0 /100.0 |
29 /29 |
1A03_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-3 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 100.0 /100.0 |
30 /30 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 100.0 /100.0 |
30 /30 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 96.9 /97.4 |
32 /32 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 97.1 /97.4 |
34 /34 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | B2MG_HUMAN Beta-2-microglobulin[100 aa] | C | 97.1 /97.4 |
34 /34 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | B2MG_HUMAN Beta-2-microglobulin[99 aa] | F | 96.9 /97.4 |
32 /32 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA-2-MICROGLOBULIN[99 aa] | A | 97.0 /97.5 |
33 /33 |
1A11_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-11 ALPHA.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | B2MG_HUMAN BETA-2-MICROGLOBULIN[99 aa] | C | 97.0 /97.5 |
33 /33 |
1A11_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-11 ALPHA.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 96.9 /97.4 |
32 /32 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 97.1 /97.4 |
34 /34 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 96.8 /97.4 |
31 /31 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 97.1 /97.4 |
35 /35 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 97.1 /97.4 |
34 /34 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | B2MG_HUMAN Beta-2-microglobulin[100 aa] | G | 97.1 /97.4 |
34 /34 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 97.1 /97.4 |
34 /34 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 97.1 /97.4 |
35 /35 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | B2MG_HUMAN Beta-2-microglobulin[100 aa] | G | 96.9 /97.4 |
32 /32 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 96.9 /97.4 |
32 /32 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | B2MG_HUMAN Beta-2-microglobulin[100 aa] | F | 96.9 /97.4 |
32 /32 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 97.0 /97.4 |
33 /33 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | B2MG_HUMAN Beta-2-microglobulin[100 aa] | F | 97.1 /97.4 |
34 /34 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | B2MG_HUMAN Beta-2-microglobulin[99 aa] | D | 100.0 /100.0 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 96.9 /97.4 |
32 /32 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | B2MG_HUMAN Beta-2-microglobulin[99 aa] | E | 97.0 /97.5 |
33 /33 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.1 /96.0 |
29 /29 |
HLA-A*3003 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.5 /96.7 |
31 /31 |
HLA-A*3001 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.3 /96.0 |
30 /30 |
HLA-A*3003 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.5 /96.0 |
31 /31 |
HLA-A*3003 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 96.7 /97.4 |
30 /30 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 96.9 /97.4 |
32 /32 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[101 aa] | A | 100.0 /99.6 |
36 /36 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 100.0 /99.6 |
33 /33 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 100.0 /100.0 |
30 /30 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 100.0 /100.0 |
32 /32 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 100.0 /100.0 |
29 /29 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 96.9 /97.5 |
32 /32 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 100.0 /100.0 |
35 /35 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 96.9 /97.4 |
32 /32 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 96.9 /97.4 |
32 /32 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | B2MG_HUMAN Beta-2-microglobulin[100 aa] | G | 97.0 /97.4 |
33 /33 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | B2MG_HUMAN Beta-2-microglobulin[100 aa] | J | 96.9 /97.5 |
32 /32 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 97.1 /97.5 |
34 /34 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 97.1 /97.5 |
35 /35 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | B2MG_HUMAN Beta-2-microglobulin[100 aa] | G | 97.0 /97.4 |
33 /33 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | B2MG_HUMAN Beta-2-microglobulin[100 aa] | J | 96.9 /97.4 |
32 /32 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 97.1 /97.4 |
34 /34 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 97.0 /97.5 |
33 /33 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[98 aa] | A | 96.9 /97.4 |
32 /32 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | B2MG_HUMAN Beta-2-microglobulin[97 aa] | F | 96.8 /97.4 |
31 /31 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | B2MG_HUMAN Beta-2-microglobulin[99 aa] | D | 100.0 /100.0 |
30 /30 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 100.0 /100.0 |
32 /32 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 97.0 /97.5 |
33 /33 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 97.0 /97.4 |
33 /33 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 97.0 /97.5 |
33 /33 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 97.0 /97.5 |
33 /33 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 97.1 /97.4 |
34 /34 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[101 aa] | D | 100.0 /100.0 |
33 /33 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 100.0 /100.0 |
32 /32 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[99 aa] | D | 100.0 /100.0 |
32 /32 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 96.9 /97.4 |
32 /32 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[101 aa] | A | 100.0 /100.0 |
34 /34 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 100.0 /96.0 |
28 /28 |
HLA-A*02:01 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 96.9 /96.7 |
32 /32 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
FA | B2MG_HUMAN Beta-2-microglobulin[99 aa] | EA | 96.8 /96.7 |
31 /31 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | B2MG_HUMAN Beta-2-microglobulin[99 aa] | F | 96.9 /96.7 |
32 /32 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
KA | B2MG_HUMAN Beta-2-microglobulin[99 aa] | JA | 97.0 /96.7 |
33 /33 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | B2MG_HUMAN Beta-2-microglobulin[99 aa] | K | 96.8 /96.7 |
31 /31 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
PA | B2MG_HUMAN Beta-2-microglobulin[99 aa] | OA | 96.9 /96.7 |
32 /32 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q | B2MG_HUMAN Beta-2-microglobulin[99 aa] | P | 97.1 /96.7 |
34 /34 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
UA | B2MG_HUMAN Beta-2-microglobulin[98 aa] | TA | 96.7 /96.7 |
30 /30 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V | B2MG_HUMAN Beta-2-microglobulin[99 aa] | U | 96.8 /96.7 |
31 /31 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AA | B2MG_HUMAN Beta-2-microglobulin[99 aa] | Z | 97.0 /96.7 |
33 /33 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | B2MG_HUMAN Beta-2-microglobulin[99 aa] | C | 97.0 /96.7 |
33 /33 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 97.0 /96.7 |
33 /33 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 96.8 /97.5 |
31 /31 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 96.9 /97.5 |
32 /32 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
F | B2MG_HUMAN Beta-2-microglobulin[98 aa] | A | 100.0 /97.5 |
1 /1 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | B2MG_HUMAN Beta-2-microglobulin[99 aa] | C | 96.4 /97.5 |
28 /28 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | B2MG_HUMAN Beta-2-microglobulin[98 aa] | E | 96.9 /97.5 |
32 /32 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 96.8 /97.4 |
31 /31 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 100.0 /97.4 |
2 /2 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | B2MG_HUMAN Beta-2-microglobulin[100 aa] | C | 96.9 /97.4 |
32 /32 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | B2MG_HUMAN Beta-2-microglobulin[98 aa] | E | 96.4 /97.4 |
28 /28 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | B2MG_HUMAN Beta-2-microglobulin[99 aa] | C | 97.0 /97.4 |
33 /33 |
MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | B2MG_HUMAN Beta-2-microglobulin[99 aa] | H | 97.1 /97.5 |
34 /34 |
MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | B2MG_HUMAN Beta-2-microglobulin[99 aa] | I | 96.9 /97.4 |
32 /32 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M | B2MG_HUMAN Beta-2-microglobulin[99 aa] | L | 96.9 /97.4 |
32 /32 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P | B2MG_HUMAN Beta-2-microglobulin[99 aa] | O | 96.7 /97.4 |
30 /30 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S | B2MG_HUMAN Beta-2-microglobulin[99 aa] | R | 96.8 /97.4 |
31 /31 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NCAP_CVHSA SARS NUCLEOCAPSID PEPTIDE[9 aa] | A | 89.7 /97.5 |
29 /29 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa] | A | 90.0 /97.4 |
30 /30 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | DNA polymerase PEPTIDE HOMOLOGUE[10 aa] | A | 88.0 /97.4 |
25 /25 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | R4P6M5_9INFA Nucleocapsid protein[11 aa] | A | 85.2 /97.4 |
27 /27 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | R4X2K3_9INFA Nucleoprotein[11 aa] | A | 84.0 /97.4 |
25 /25 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | KI2S2_HUMAN Killer cell immunoglobulin-like receptor 2DS2[190 .. | C | 100.0 /97.4 |
11 /11 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | KI2S2_HUMAN Killer cell immunoglobulin-like receptor 2DS2[190 .. | F | 100.0 /97.4 |
12 /12 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | A14_VACCW peptide from Virion membrane protein A14[9 aa] | C | 86.7 /97.4 |
30 /30 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | A14_VACCW peptide from Virion membrane protein A14[9 aa] | F | 87.1 /97.4 |
31 /31 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Epstein Barr Virus, Latent membrane protein 2 epit.. | A | 84.6 /97.4 |
26 /26 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Epstein Barr Virus, Latent Membrane Protein 2 epit.. | A | 84.6 /97.4 |
13 /13 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Epstein Barr Virus, Latent Membrane Protein 2 epit.. | A | 81.8 /97.4 |
11 /11 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Epstein Barr Virus, Latent membrane protein-2 epit.. | A | 88.9 /97.4 |
18 /18 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GTS1 peptide[10 aa] | A | 92.6 /97.4 |
27 /27 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | GTS1 peptide[10 aa] | D | 96.2 /97.4 |
26 /26 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | GTS1 peptide[10 aa] | G | 89.7 /97.4 |
29 /29 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GTS1 peptide[10 aa] | A | 89.3 /97.4 |
28 /28 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | GTS1 peptide[10 aa] | F | 89.3 /97.4 |
28 /28 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GTS3 peptide[10 aa] | A | 86.7 /97.4 |
30 /30 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | GTS3 peptide[10 aa] | D | 86.7 /97.4 |
30 /30 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | GTS3 peptide[10 aa] | G | 89.7 /97.4 |
29 /29 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GTS3 peptide[10 aa] | A | 90.0 /97.4 |
30 /30 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | GTS3 peptide[10 aa] | F | 89.7 /97.4 |
29 /29 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | A0A087WSZ9_HUMAN K7N5N2_HUMAN T-cell receptor alpha variable 30,T-cell receptor,.. | A | 75.0 /97.4 |
4 /4 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | A0A087WSZ9_HUMAN K7N5N2_HUMAN T-cell receptor alpha variable 30,T-cell receptor,.. | F | 80.0 /97.4 |
5 /5 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | A0A087WSZ9_HUMAN K7N5N2_HUMAN T-cell receptor alpha variable 30,T-cell receptor,.. | A | 80.0 /97.4 |
5 /5 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | A0A087WSZ9_HUMAN K7N5N2_HUMAN T-cell receptor alpha variable 30,T-cell receptor,.. | F | 83.3 /97.4 |
6 /6 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa] | A | 85.2 /97.4 |
27 /27 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ALA-THR-ILE-GLY-THR[5 aa] | A | 76.9 /97.4 |
13 /13 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | ALA-MET-TYR-LYS[4 aa] | A | 84.6 /97.4 |
13 /13 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | RASN_HUMAN KRAS peptide (VVVGAGGVGK)[7 aa] | D | 91.3 /97.4 |
23 /23 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | RASN_HUMAN KRAS peptide (VVVGAGGVGK)[6 aa] | G | 90.9 /97.4 |
22 /22 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RASN_HUMAN KRAS G12D peptide (VVVGADGVGK)[8 aa] | A | 90.9 /97.5 |
22 /22 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | RASN_HUMAN KRAS G12D peptide (VVVGADGVGK)[8 aa] | D | 91.3 /97.5 |
23 /23 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | RASN_HUMAN KRAS G12D peptide (VVVGADGVGK)[8 aa] | G | 87.5 /97.4 |
24 /24 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | RASN_HUMAN KRAS G12D peptide (VVVGADGVGK)[8 aa] | J | 90.9 /97.4 |
22 /22 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TCR alpha[191 aa] | A | 91.7 /97.4 |
12 /12 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | TCR beta[246 aa] | A | 100.0 /97.4 |
5 /5 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | TCR beta[245 aa] | A | 100.0 /97.5 |
5 /5 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | TCR beta[244 aa] | A | 100.0 /97.4 |
5 /5 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | TCR beta[244 aa] | F | 100.0 /97.4 |
5 /5 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RASN_HUMAN KRAS G12D peptide (VVVGADGVGK)[10 aa] | A | 88.5 /97.5 |
26 /26 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RASN_HUMAN KRAS G12D peptide (VVVGADGVGK)[10 aa] | A | 89.7 /97.4 |
29 /29 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | RASN_HUMAN KRAS G12D peptide (VVVGADGVGK)[10 aa] | F | 89.3 /97.4 |
28 /28 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TCR alpha[163 aa] | A | 90.0 /97.4 |
10 /10 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | TCR alpha[179 aa] | F | 90.0 /97.4 |
10 /10 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NCAP_INBSI Nucleoprotein peptide KTNGNAFIGK[10 aa] | A | 85.7 /97.5 |
28 /28 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | NCAP_INBSI Nucleoprotein peptide KTNGNAFIGK[10 aa] | D | 85.7 /97.4 |
28 /28 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NS1_INBSJ Non-structural protein 1 peptide RVLVNGTFLK[10 aa].. | A | 87.1 /97.4 |
31 /31 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | peptide KRAS-G12V-9[9 aa] | A | 81.8 /96.7 |
22 /22 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
GA | peptide KRAS-G12V-9[9 aa] | EA | 85.7 /96.7 |
21 /21 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | peptide KRAS-G12V-9[9 aa] | F | 87.5 /96.7 |
24 /24 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
LA | peptide KRAS-G12V-9[9 aa] | JA | 84.0 /96.7 |
25 /25 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M | peptide KRAS-G12V-9[9 aa] | K | 86.4 /96.7 |
22 /22 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
QA | peptide KRAS-G12V-9[9 aa] | OA | 81.8 /96.7 |
22 /22 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R | peptide KRAS-G12V-9[9 aa] | P | 81.8 /96.7 |
22 /22 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
VA | peptide KRAS-G12V-9[9 aa] | TA | 86.4 /96.7 |
22 /22 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W | peptide KRAS-G12V-9[9 aa] | U | 81.0 /96.7 |
21 /21 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
BA | peptide KRAS-G12V-9[9 aa] | Z | 81.0 /96.7 |
21 /21 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | peptide KRAS-G12V-9[9 aa] | C | 83.3 /96.7 |
24 /24 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | KRAS-G12V nonamer peptide[9 aa] | C | 84.0 /97.4 |
25 /25 |
MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | KRAS-G12V nonamer peptide[9 aa] | H | 85.2 /97.5 |
27 /27 |
MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | KRAS-G12V nonamer peptide[9 aa] | I | 88.0 /97.4 |
25 /25 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N | KRAS-G12V nonamer peptide[9 aa] | L | 88.0 /97.4 |
25 /25 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q | KRAS-G12V nonamer peptide[9 aa] | O | 88.0 /97.4 |
25 /25 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T | KRAS-G12V nonamer peptide[9 aa] | R | 84.6 /97.4 |
26 /26 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | T-cell receptor alpha chain[183 aa] | C | 90.9 /97.4 |
11 /11 |
MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | T-cell receptor alpha chain[182 aa] | H | 90.9 /97.5 |
11 /11 |
MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | TCR alpha chain[175 aa] | I | 88.9 /97.4 |
9 /9 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | TCR alpha chain[175 aa] | L | 90.0 /97.4 |
10 /10 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | TCR alpha chain[176 aa] | O | 88.9 /97.4 |
9 /9 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | TCR alpha chain[177 aa] | R | 87.5 /97.4 |
8 /8 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | T-cell receptor beta chain[236 aa] | C | 100.0 /97.4 |
9 /9 |
MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | T-cell receptor beta chain[239 aa] | H | 100.0 /97.5 |
12 /12 |
MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | TCR beta chain[239 aa] | I | 100.0 /97.4 |
8 /8 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TCR beta chain[237 aa] | L | 100.0 /97.4 |
10 /10 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | TCR beta chain[239 aa] | O | 100.0 /97.4 |
9 /9 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | TCR beta chain[238 aa] | R | 100.0 /97.4 |
8 /8 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | SPIKE_SARS2 Spike protein S2' [10 aa] | A | 87.1 /97.4 |
31 /31 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | SPIKE_SARS2 Spike protein S2' [10 aa] | C | 86.7 /97.4 |
30 /30 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | SPIKE_SARS2 Spike protein S2' [10 aa] | E | 87.1 /97.4 |
31 /31 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TCR alpha chain[198 aa] | A | 88.9 /96.7 |
9 /9 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
HA | TCR alpha chain[198 aa] | EA | 88.9 /96.7 |
9 /9 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | TCR alpha chain[198 aa] | F | 88.9 /96.7 |
9 /9 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
MA | TCR alpha chain[198 aa] | JA | 88.9 /96.7 |
9 /9 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N | TCR alpha chain[198 aa] | K | 88.9 /96.7 |
9 /9 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
RA | TCR alpha chain[198 aa] | OA | 88.9 /96.7 |
9 /9 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S | TCR alpha chain[198 aa] | P | 87.5 /96.7 |
8 /8 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
WA | TCR alpha chain[198 aa] | TA | 88.9 /96.7 |
9 /9 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
X | TCR alpha chain[198 aa] | U | 87.5 /96.7 |
8 /8 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
CA | TCR alpha chain[198 aa] | Z | 88.9 /96.7 |
9 /9 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | TCR beta chain[240 aa] | A | 100.0 /96.7 |
10 /10 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
IA | TCR beta chain[240 aa] | EA | 100.0 /96.7 |
10 /10 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | TCR beta chain[240 aa] | F | 100.0 /96.7 |
10 /10 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
NA | TCR beta chain[240 aa] | JA | 100.0 /96.7 |
11 /11 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O | TCR beta chain[240 aa] | K | 100.0 /96.7 |
10 /10 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
SA | TCR beta chain[240 aa] | OA | 100.0 /96.7 |
11 /11 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T | TCR beta chain[240 aa] | P | 100.0 /96.7 |
8 /8 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
XA | TCR beta chain[240 aa] | TA | 100.0 /96.7 |
11 /11 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Y | TCR beta chain[240 aa] | U | 100.0 /96.7 |
10 /10 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
DA | TCR beta chain[240 aa] | Z | 100.0 /96.7 |
11 /11 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | TCR alpha chain[194 aa] | C | 84.6 /96.7 |
13 /13 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | TCR beta chain[242 aa] | C | 100.0 /96.7 |
7 /7 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RASK_HUMAN KRAS-G12wt-9[9 aa] | A | 88.0 /96.7 |
25 /25 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | POL_HV1Z2 nonamer reverse transcriptase (AIFQSSMTK)[9 aa] | A | 86.2 /97.5 |
29 /29 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | POL_HV1Z2 nonamer reverse transcriptase (AIFQSSMTK)[9 aa] | D | 85.7 /97.5 |
28 /28 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q9YV12_9HIV1 RT313 peptide[9 aa] | A | 100.0 /100.0 |
25 /25 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | peptide[9 aa] | A | 85.2 /97.4 |
27 /27 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | peptide[9 aa] | E | 86.2 /97.5 |
29 /29 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RT313[9 aa] | A | 80.0 /96.0 |
25 /25 |
HLA-A*3003 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | ALA-ILE-PHE-GLN-SER-SER-MET-THR-LYS[9 aa] | A | 91.3 /96.7 |
23 /23 |
HLA-A*3001 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HIV-1 RT[9 aa] | A | 100.0 /96.0 |
22 /22 |
HLA-A*02:01 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | MTB[9 aa] | A | 79.3 /96.0 |
29 /29 |
HLA-A*3003 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NP44[9 aa] | A | 78.6 /96.0 |
28 /28 |
HLA-A*3003 |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
365 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
MG
|
A | 100.0 /97.5 |
1 /1 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
I |
MG
|
D | 100.0 /97.5 |
1 /1 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
J |
MG
|
D | 100.0 /97.5 |
1 /1 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
CL
|
A | 50.0 /97.4 |
2 /2 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
CL
|
D | 50.0 /97.4 |
2 /2 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
CL
|
A | 100.0 /97.5 |
3 /3 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
CL
|
A | 100.0 /97.5 |
4 /4 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W |
CL
|
C | 100.0 /97.4 |
6 /6 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
CA |
CL
|
E | 100.0 /97.4 |
6 /6 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
DA |
CL
|
E | 83.3 /97.4 |
6 /6 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
NA
|
A | 100.0 /97.5 |
2 /2 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
NA
|
A | 100.0 /97.5 |
1 /1 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
EA |
NA
|
E | 100.0 /97.4 |
2 /2 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
365 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() |
![]() |
F | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
4 /4 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G | alpha-D-glucopyranose-(1-3)-alpha-D-mannopyranose-.. | D | 100.0 /100.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
365 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q5S3G3_HUMAN HLA class I histocompatibility antigen[275 aa] | A | 100.0 /97.5 |
2 /2 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Q5S3G3_HUMAN HLA class I histocompatibility antigen[275 aa] | A | 100.0 /97.5 |
5 /5 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | Q5S3G3_HUMAN HLA class I histocompatibility antigen[275 aa] | C | 100.0 /97.5 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Q5S3G3_HUMAN HLA class I histocompatibility antigen[275 aa] | C | 100.0 /97.5 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | Q5S3G3_HUMAN HLA class I histocompatibility antigen[275 aa] | E | 100.0 /97.5 |
7 /7 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q5S3G3_HUMAN HLA class I histocompatibility antigen[275 aa] | E | 100.0 /97.5 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q5S3G3_HUMAN HLA class I histocompatibility antigen[274 aa] | A | 100.0 /97.4 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Q5S3G3_HUMAN HLA class I histocompatibility antigen[273 aa] | A | 100.0 /97.4 |
2 /2 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
A | Q5S3G3_HUMAN HLA class I histocompatibility antigen[273 aa] | C | 100.0 /97.4 |
1 /1 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Q5S3G3_HUMAN HLA class I histocompatibility antigen[273 aa] | C | 100.0 /97.4 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | Q5S3G3_HUMAN HLA class I histocompatibility antigen[273 aa] | E | 100.0 /97.4 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q5S3G3_HUMAN HLA class I histocompatibility antigen[274 aa] | E | 100.0 /97.4 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
365 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
GOL
|
A | 100.0 /97.5 |
2 /2 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /97.5 |
2 /2 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /97.5 |
4 /4 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 100.0 /97.5 |
3 /3 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 80.0 /97.5 |
5 /5 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
A | 100.0 /97.5 |
2 /2 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
GOL
|
A | 100.0 /97.4 |
3 /3 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
GOL
|
A | 100.0 /97.4 |
4 /4 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
GOL
|
A | 100.0 /97.4 |
3 /3 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /97.4 |
1 /1 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
D |
GOL
|
A | 100.0 /97.4 |
2 /2 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
GOL
|
A | 100.0 /97.4 |
5 /5 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
GOL
|
A | 100.0 /97.4 |
4 /4 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
GOL
|
A | 75.0 /97.4 |
4 /4 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
GOL
|
A | 100.0 /97.4 |
5 /5 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
O |
GOL
|
A | 100.0 /97.4 |
1 /1 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
GOL
|
E | 50.0 /97.5 |
2 /2 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R |
GOL
|
E | 100.0 /97.5 |
5 /5 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
D |
GOL
|
A | 100.0 /97.4 |
1 /1 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
GOL
|
A | 100.0 /97.4 |
4 /4 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
GOL
|
A | 100.0 /97.4 |
6 /6 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /97.4 |
1 /1 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /97.4 |
2 /2 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 100.0 /97.4 |
3 /3 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 100.0 /97.4 |
4 /4 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
GOL
|
A | 100.0 /97.4 |
5 /5 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
GOL
|
A | 100.0 /97.4 |
3 /3 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /97.4 |
3 /3 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /97.4 |
5 /5 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
D |
GOL
|
A | 100.0 /100.0 |
1 /1 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
GOL
|
A | 100.0 /100.0 |
4 /4 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
GOL
|
A | 100.0 /100.0 |
4 /4 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
GOL
|
A | 100.0 /100.0 |
5 /5 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 100.0 /100.0 |
2 /2 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 100.0 /100.0 |
3 /3 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
GOL
|
A | 100.0 /97.5 |
3 /3 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
GOL
|
A | 100.0 /100.0 |
5 /5 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /100.0 |
5 /5 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /100.0 |
3 /3 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 100.0 /100.0 |
4 /4 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 100.0 /100.0 |
4 /4 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
M |
GOL
|
A | 100.0 /100.0 |
1 /1 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
R |
GOL
|
A | 100.0 /100.0 |
1 /1 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
FMT
|
A | 100.0 /100.0 |
4 /4 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
FMT
|
A | 100.0 /100.0 |
3 /3 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
ACT
|
A | 100.0 /100.0 |
1 /1 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
MES
|
A | 100.0 /99.6 |
4 /4 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
MES
|
A | 100.0 /99.6 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
MES
|
A | 100.0 /99.6 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
MES
|
A | 100.0 /99.6 |
4 /4 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
MES
|
A | 100.0 /99.6 |
2 /2 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
PG4
|
A | 100.0 /99.6 |
2 /2 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
PG4
|
A | 100.0 /99.6 |
6 /6 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
IMD
|
A | 100.0 /99.6 |
7 /7 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
IMD
|
A | 100.0 /99.6 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
D |
SO4
|
A | 100.0 /97.5 |
1 /1 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
SO4
|
A | 66.7 /97.5 |
3 /3 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
K |
SO4
|
A | 100.0 /97.5 |
1 /1 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
D |
SO4
|
A | 100.0 /97.4 |
1 /1 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
E |
SO4
|
A | 100.0 /97.4 |
1 /1 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
SO4
|
A | 100.0 /97.4 |
3 /3 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
SO4
|
A | 100.0 /99.6 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
SO4
|
A | 100.0 /99.6 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
SO4
|
A | 100.0 /99.6 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
SO4
|
A | 100.0 /99.6 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
I |
SO4
|
A | 100.0 /99.6 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
A | 100.0 /99.6 |
2 /2 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
K |
SO4
|
A | 100.0 /99.6 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
O |
SO4
|
A | 100.0 /99.6 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
E |
SO4
|
A | 100.0 /97.5 |
1 /1 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
SO4
|
A | 100.0 /100.0 |
3 /3 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
E |
SO4
|
A | 100.0 /100.0 |
1 /1 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
SO4
|
A | 100.0 /100.0 |
4 /4 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
M |
SO4
|
D | 100.0 /97.5 |
2 /2 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
SO4
|
G | 100.0 /97.4 |
3 /3 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
SO4
|
G | 100.0 /97.4 |
2 /2 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
P |
SO4
|
J | 100.0 /97.4 |
2 /2 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
SO4
|
A | 100.0 /97.4 |
4 /4 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
K |
SO4
|
D | 100.0 /97.5 |
2 /2 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
SO4
|
A | 50.0 /97.4 |
2 /2 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
SO4
|
A | 100.0 /100.0 |
1 /1 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
SO4
|
A | 100.0 /100.0 |
3 /3 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
SO4
|
D | 100.0 /100.0 |
5 /5 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
D | 100.0 /100.0 |
1 /1 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
SO4
|
D | 100.0 /100.0 |
4 /4 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
SO4
|
A | 100.0 /100.0 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
SO4
|
A | 100.0 /100.0 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
SO4
|
A | 100.0 /100.0 |
2 /2 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
SO4
|
A | 100.0 /100.0 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
SO4
|
A | 100.0 /100.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
I |
SO4
|
A | 100.0 /100.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
A | 100.0 /100.0 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
SO4
|
A | 100.0 /100.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
SO4
|
A | 100.0 /100.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
SO4
|
A | 100.0 /97.5 |
4 /4 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
SO4
|
A | 100.0 /97.5 |
5 /5 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
PEG
|
A | 100.0 /97.4 |
5 /5 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
PEG
|
A | 100.0 /97.4 |
3 /3 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
PEG
|
E | 83.3 /97.5 |
6 /6 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S |
PEG
|
E | 100.0 /97.5 |
5 /5 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
PEG
|
E | 100.0 /97.5 |
2 /2 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
PEG
|
A | 100.0 /99.6 |
5 /5 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
PEG
|
A | 100.0 /99.6 |
4 /4 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
PEG
|
A | 100.0 /99.6 |
4 /4 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
K |
PEG
|
A | 100.0 /100.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
PEG
|
A | 100.0 /97.5 |
2 /2 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
PEG
|
E | 100.0 /97.5 |
4 /4 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V |
PEG
|
C | 100.0 /97.4 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
EDO
|
A | 100.0 /99.6 |
5 /5 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
EDO
|
A | 100.0 /99.6 |
4 /4 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
L |
EDO
|
A | 100.0 /99.6 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
EDO
|
A | 100.0 /99.6 |
2 /2 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
EDO
|
A | 100.0 /97.5 |
2 /2 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
EDO
|
A | 100.0 /97.5 |
4 /4 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
EDO
|
A | 100.0 /97.5 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
EDO
|
A | 100.0 /97.5 |
2 /2 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
EDO
|
A | 100.0 /97.5 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
EDO
|
A | 100.0 /97.5 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
EDO
|
E | 100.0 /97.5 |
2 /2 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
EDO
|
A | 100.0 /97.4 |
4 /4 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
EDO
|
A | 75.0 /97.4 |
4 /4 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
EDO
|
A | 66.7 /97.4 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
EDO
|
A | 100.0 /97.4 |
6 /6 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
EDO
|
A | 100.0 /97.4 |
1 /1 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
EDO
|
A | 100.0 /97.4 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R |
EDO
|
C | 87.5 /97.4 |
8 /8 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S |
EDO
|
C | 100.0 /97.4 |
5 /5 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
EDO
|
C | 100.0 /97.4 |
2 /2 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
U |
EDO
|
C | 100.0 /97.4 |
1 /1 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
X |
EDO
|
C | 100.0 /97.4 |
2 /2 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Z |
EDO
|
C | 100.0 /97.4 |
2 /2 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
BA |
EDO
|
E | 100.0 /97.4 |
5 /5 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
FA |
EDO
|
E | 100.0 /97.4 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
GA |
EDO
|
E | 100.0 /97.4 |
2 /2 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. |